Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 355

What unbelievable circumstances!

What an unbelievable couple of months! The non-essential parts of the Australian economy were shut down in a matter of weeks, as was the case in many other countries around the world, notably the US and UK. We are all dusting off the history books on the 1918 Spanish Flu pandemic and becoming part time virologists and epidemiologists!

To truly understand the unfolding crises, it’s critical to have the appropriate perspective on how things may unfold from here and hence inform decision making in a time of significant uncertainty.

No portfolio was positioned for a shutdown

March 2020 was an extremely volatile month as the reality of social distancing and other containment measures designed to 'flatten the (infection) curve' kicked in. Records were broken as markets swung wildly, oil was crushed and governments stepped up to the plate and injected record levels of stimulus aided by central banks who provided support to the plumbing of the financial system (credit markets) and used up their last remaining interest rate cut ammunition.

The figure below shows COVID-19 delivered one of the largest growth shocks in a century, but also the shortest. (The figure shows peak-to-trough change in global real GDP growth, negative indicates recessions, zero indicates expansions. Annual data pre-1970, then quarterly).

The fastest downward correction

The Australian market was no exception to this rapid fall, as shown below.

ASX 200: COVID-19 vs GFC, peak rebased to 100, as at 31 March 2020

Markets reacted to both the spread of COVID-19 and the containment measures designed to slow it (the health and economic crises are currently joined at the hip), which was basically to bring non-essential economic activity to a halt. It is fair to say that our view in early 2020 of a housing and stimulus-led domestic recovery, no longer holds.

Containment measures are resulting in a sudden loss of revenue for Australian companies and downgrades are inevitable. However if history is a guide, the current -9% consensus downgrades since the peak are grossly understating the pain. On average since 1972, the peak-to-trough fall for earnings-per-share (EPS) in prior recessions has been closer to -30%.

Peak-to-trough EPS fall in prior recessions for Australian companies

Being approximately right, not precisely wrong

Within our Australian equity portfolio, we have always thought in scenarios. Getting a price and timing exactly right is an impossible target and definitely not practicable when building or reducing positions as part of managing an equity portfolio. Our approach is to be approximately right as opposed to precisely wrong.

Markets will recover when things stop getting worse, which relates to both the health and economic crises, but when is that? The framework for our modeling scenarios is based on three phases:

  1. Containment phase – social distancing and other containment measures to slow the spread of COVID-19 so as to not overburden the health care system. This is having a positive impact on the new infection rates (ie slowing) and we are almost through this phase.
  2. Hibernation phase – continuation of containment measures until a point where infections are 'under control', particularly community spread. How long this will be for is the big question and greatest uncertainty for markets.
  3. Recovery phase – gradual removal of containment measures. It is considered likely that some measures like social distancing are with us for some time, potentially until a vaccine is available. Whilst there will be a recovery, we don’t expect business as usual any time soon.

Markets should recover at some point between phase 2 and 3, particularly once confidence grows that infections are under control.

The recovery is likely to be a function of four key variables:

  1. Length of hibernation (how much economic damage)
  2. Containment measures in place (what level of activity and type of activity comes back)
  3. Size and duration of economic stimulus from Governments and central banks, and
  4. Psychological impact and behavioural change of businesses and consumers.

Portfolio management in this market

The benchmark of investment success will be the next 12 months as opposed to the next 12 weeks. We were active in March to reposition the portfolio to this new environment. We expect a potential strong divergence in stock performance over the next 12-24 months and see this as a market which will reward clear thinking of the path to recovery.

Portfolio activity snapshot:

Balance sheet tests – our first step in February was to assess the balance sheets and liquidity position of portfolio holdings and in particular the ability to withstand 3-6 months of little to no revenue. This led to us exiting several positions.

Investment market sensitivity – reduced positions in insurance and financial services. Declining equity markets, credit spreads blowing out, and other asset market falls hurt not only the earnings but can also impact the capital positions of financials.

Consumer – consumer activity and spend has halted. Reduced exposure to housing, retail and toll road infrastructure.

Beneficiaries – new positions in Fisher & Paykel Healthcare and Fortescue. The virus is creating strong respirator demand for Fisher & Paykel Healthcare, and Fortescue provides additional exposure to iron ore (in addition to Rio Tinto) where we expect iron ore to remain strong given China’s steel-intensive stimulus.

Quality growth opportunities – fear clouds the market’s judgement of quality, long-term growers. We increased our exposure to IT via potential long-term winners, as valuations sold off heavily. We also added IDP Education as it fell to its lowest valuation in over two years.

The path from here

We are currently heavily focused on what the shape of recovery could look like for stocks and sectors. We expect it to be different for various parts of the market, depending largely, on how the previously mentioned four key variables play out at a stock and sector level.

How you want to position your portfolio for a ‘V’, ‘U’ or ‘L’ shaped recovery is obviously very different.

In light of the strong market rally from the 23 March lows, we are expecting a wave of capital raisings as companies use this window of opportunity to manage debt and liquidity risks. We believe markets have and will provide liquidity to the deserving, but not all companies will be so lucky. Expect big earnings downgrades. We all know they’re coming, but how will markets react to the magnitude of downgrades some haven’t seen in their lifetime?

We expect more volatility but equally new opportunities. Our extensive experience from investing through previous crises (Asian Financial crises, Dot-com Bust, GFC), strong focus on quality growth companies driven by our fundamental research, and insights from our global research platform position us well to seek to generate strong performance in the long term despite the short-term uncertainty of current events.

 

Randal Jenneke is Head of Australian Equities and Portfolio Manager at T. Rowe Price Australia. This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision.

 


 

Leave a Comment:

RELATED ARTICLES

Australia 2021 market outlook: cautiously optimistic

Which companies will do well in the turmoil of 2020?

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.